WOODBRIDGE, Conn.–(BUSINESS WIRE)–LambdaVision, a pre-clinical-stage biotech advancing on-Earth and microgravity bioprocesses, today announced the signing of a memorandum of understanding with Vast to support future research and manufacturing activities aboard Vast’s Haven-1 and future commercial space stations. The collaboration will build on LambdaVision’s successful microgravity manufacturing program, which has demonstrated through nine missions to the International Space Station that micr
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
